Michael Feld

EVP & President, Life Sciences, Becton Dickinson.

Companies

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

As of each latest filing. The line shows shares held over time.

Recent filings

Trade performance

DateStockTradeValueReturn sinceVs S&P sinceVs S&P, 1 year
Sep 28, 2026BDXSale$14.0K+4.3%−3.5%
Aug 26, 2026BDXSale$31.1K+0.8%−0.1%
Jul 27, 2026BDXSale$11.8K+20.7%−16.2%
Jun 26, 2026BDXSale$11.5K+23.0%−17.1%
May 26, 2026BDXSale$11.1K+29.8%−27.0%
Apr 27, 2026BDXSale$11.2K+27.6%−19.7%
Mar 26, 2026BDXSale$11.8K+21.8%−2.2%
Feb 26, 2026BDXSale$13.6K+8.5%+3.4%
Jan 26, 2026BDXSale$15.2K+19.9%−8.5%
Dec 26, 2025BDXSale$14.5K+24.2%−12.4%
Dec 1, 2025BDXSale$14.5K+27.2%−13.7%
Oct 27, 2025BDXSale$10.6K+30.4%−17.8%
Sep 26, 2025BDXSale$10.5K+32.1%−15.5%−11.0%
Aug 22, 2025BDXSale$11.3K+22.2%−2.6%−3.2%

Returns are price-only (no dividends), measured from the trade date.